CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q2 2021 Results – Earnings Call Transcript

CytoSorbents Corporation (CTSO) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET
Company Participants
Terri Anne Powers – VP, IR and Corporate Communications
Phillip Chan – Chief Executive Officer
Efthymios Deliargyris – Chief Medical Officer

Click here to view the original article.